Evaluation of Lung Clearance Index in Cystic Fibrosis (CF) Patients, Infected With P.Aeruginosa
Clinical trial NCT02248922 · TERMINATED
Trial details
- NCT number
- NCT02248922
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-27
- Primary completion
- 2017-04-10
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.